464 related articles for article (PubMed ID: 16622298)
1. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome.
Bray GA; Bellanger T
Endocrine; 2006 Feb; 29(1):109-17. PubMed ID: 16622298
[TBL] [Abstract][Full Text] [Related]
2. Dyslipidemia in the metabolic syndrome in children.
Gidding SS
J Cardiometab Syndr; 2006; 1(4):282-5. PubMed ID: 17679808
[TBL] [Abstract][Full Text] [Related]
3. Association of age and sex with cardiovascular risk factors and insulin sensitivity in overweight children and adolescents.
Koenigsberg J; Boyd GS; Gidding SS; Hassink SG; Falkner B
J Cardiometab Syndr; 2006; 1(4):253-8. PubMed ID: 17679813
[TBL] [Abstract][Full Text] [Related]
4. Weight, the metabolic syndrome, and coronary heart disease in type 2 diabetes: associations among a national French sample of adults with diabetes-the ENTRED study.
Hillier TA; Fosse S; Balkau B; Simon D; Eschwège E; Fagot-Campagna A
J Cardiometab Syndr; 2006; 1(5):318-25. PubMed ID: 17679788
[TBL] [Abstract][Full Text] [Related]
5. Health and mortality consequences of abdominal obesity: evidence from the AusDiab study.
Cameron AJ; Dunstan DW; Owen N; Zimmet PZ; Barr EL; Tonkin AM; Magliano DJ; Murray SG; Welborn TA; Shaw JE
Med J Aust; 2009 Aug; 191(4):202-8. PubMed ID: 19705980
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of diabetes and impaired glucose metabolism in younger 'at risk' UK adults: insights from the STAND programme of research.
Wilmot EG; Edwardson CL; Biddle SJ; Gorely T; Henson J; Khunti K; Nimmo MA; Yates T; Davies MJ
Diabet Med; 2013 Jun; 30(6):671-5. PubMed ID: 23506383
[TBL] [Abstract][Full Text] [Related]
7. Disease risks of childhood obesity in China.
Li YP; Yang XG; Zhai FY; Piao JH; Zhao WH; Zhang J; Ma GS
Biomed Environ Sci; 2005 Dec; 18(6):401-10. PubMed ID: 16544522
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of obesity and obesity-related health conditions in a large, multiethnic cohort of young adults in California.
Koebnick C; Smith N; Huang K; Martinez MP; Clancy HA; Kushi LH
Ann Epidemiol; 2012 Sep; 22(9):609-16. PubMed ID: 22766471
[TBL] [Abstract][Full Text] [Related]
9. The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus.
Ginsberg HN; MacCallum PR
J Cardiometab Syndr; 2009; 4(2):113-9. PubMed ID: 19614799
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of overweight/obesity and its associations with hypertension, diabetes, dyslipidemia, and metabolic syndrome: a survey in the suburban area of Beijing, 2007.
Zhang L; Zhang WH; Zhang L; Wang PY
Obes Facts; 2011; 4(4):284-9. PubMed ID: 21921651
[TBL] [Abstract][Full Text] [Related]
11. Childhood obesity and its health consequence in China.
Li Y; Yang X; Zhai F; Piao J; Zhao W; Zhang J; Ma G
Obes Rev; 2008 Mar; 9 Suppl 1():82-6. PubMed ID: 18307705
[TBL] [Abstract][Full Text] [Related]
12. Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis - a systematic review.
Wens I; Dalgas U; Stenager E; Eijnde BO
Mult Scler; 2013 Oct; 19(12):1556-64. PubMed ID: 24048545
[TBL] [Abstract][Full Text] [Related]
13. Relationship between obesity and obesity-related morbidities weakens with aging.
Canning KL; Brown RE; Jamnik VK; Kuk JL
J Gerontol A Biol Sci Med Sci; 2014 Jan; 69(1):87-92. PubMed ID: 23525474
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of dyslipidemia and metabolic syndrome risk factor in overweight and obese children.
Casavalle PL; Lifshitz F; Romano LS; Pandolfo M; Caamaño A; Boyer PM; Rodríguez PN; Friedman SM
Pediatr Endocrinol Rev; 2014 Dec; 12(2):213-23. PubMed ID: 25581987
[TBL] [Abstract][Full Text] [Related]
15. Incidence of type 2 diabetes, hypertension, and dyslipidemia in metabolically healthy obese and non-obese.
Fingeret M; Marques-Vidal P; Vollenweider P
Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):1036-1044. PubMed ID: 30139688
[TBL] [Abstract][Full Text] [Related]
16. Obesity is bad regardless of the obesity paradox for hypertension and heart disease.
Chrysant SG
J Clin Hypertens (Greenwich); 2018 May; 20(5):842-846. PubMed ID: 29665198
[No Abstract] [Full Text] [Related]
17. Nut consumption is associated with decreased health risk factors for cardiovascular disease and metabolic syndrome in U.S. adults: NHANES 1999-2004.
O'Neil CE; Keast DR; Nicklas TA; Fulgoni VL
J Am Coll Nutr; 2011 Dec; 30(6):502-10. PubMed ID: 22331685
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of high bloodpressure, hyperglycemia, dyslipidemia, metabolic syndrome and their determinants in Ethiopia: Evidences from the National NCDs STEPS Survey, 2015.
Gebreyes YF; Goshu DY; Geletew TK; Argefa TG; Zemedu TG; Lemu KA; Waka FC; Mengesha AB; Degefu FS; Deghebo AD; Wubie HT; Negeri MG; Tesema TT; Tessema YG; Regassa MG; Eba GG; Beyene MG; Yesu KM; Zeleke GT; Mengistu YT; Belayneh AB
PLoS One; 2018; 13(5):e0194819. PubMed ID: 29742131
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of the insulin resistance syndrome.
Meigs JB
Curr Diab Rep; 2003 Feb; 3(1):73-9. PubMed ID: 12643149
[TBL] [Abstract][Full Text] [Related]
20. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
